111 Capital Invests $280,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

111 Capital acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 471 shares of the biotechnology company's stock, valued at approximately $280,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Fourth Dimension Wealth LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth about $30,000. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise in the 4th quarter valued at approximately $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise in the 4th quarter valued at approximately $45,000. Elequin Capital LP bought a new position in Axon Enterprise in the 4th quarter valued at approximately $46,000. Finally, Stonebridge Financial Group LLC bought a new position in Axon Enterprise in the 4th quarter valued at approximately $53,000. Institutional investors own 79.08% of the company's stock.

Insider Buying and Selling

In other Axon Enterprise news, Director Michael Garnreiter sold 87 shares of Axon Enterprise stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $760.00, for a total transaction of $66,120.00. Following the completion of the transaction, the director now owns 24,653 shares of the company's stock, valued at $18,736,280. The trade was a 0.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,969 shares of company stock valued at $29,909,594. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Up 2.8%

NASDAQ AXON traded up $20.93 during mid-day trading on Wednesday, hitting $780.00. The company's stock had a trading volume of 557,514 shares, compared to its average volume of 734,770. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company's 50 day simple moving average is $633.63 and its 200 day simple moving average is $613.89. Axon Enterprise, Inc. has a twelve month low of $276.23 and a twelve month high of $780.62. The firm has a market capitalization of $60.72 billion, a price-to-earnings ratio of 201.55, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business's revenue for the quarter was up 31.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.15 EPS. Analysts anticipate that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of research reports. Bank of America raised their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Barclays increased their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. Finally, The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average price target of $699.55.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.